Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSUVASTATIN Cause Incorrect dose administered? 163 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 163 reports of Incorrect dose administered have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.5% of all adverse event reports for ROSUVASTATIN.

163
Reports of Incorrect dose administered with ROSUVASTATIN
0.5%
of all ROSUVASTATIN reports
2
Deaths
49
Hospitalizations

How Dangerous Is Incorrect dose administered From ROSUVASTATIN?

Of the 163 reports, 2 (1.2%) resulted in death, 49 (30.1%) required hospitalization, and 15 (9.2%) were considered life-threatening.

Is Incorrect dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 163 reports have been filed with the FAERS database.

What Other Side Effects Does ROSUVASTATIN Cause?

Myalgia (3,958) Dyspnoea (2,832) Pain (2,758) Drug ineffective (2,347) Fatigue (2,208) Rhabdomyolysis (2,173) Arthralgia (1,879) Asthma (1,843) Muscle spasms (1,843) Pain in extremity (1,686)

What Other Drugs Cause Incorrect dose administered?

TIRZEPATIDE (23,301) ADALIMUMAB (14,000) DUPILUMAB (9,907) RANITIDINE (9,337) INSULIN LISPRO (8,318) ACETAMINOPHEN (5,316) DULAGLUTIDE (5,207) SECUKINUMAB (4,524) INSULIN GLARGINE (3,070) SOMATROPIN (2,772)

Which ROSUVASTATIN Alternatives Have Lower Incorrect dose administered Risk?

ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN ROSUVASTATIN vs ROTIGOTINE ROSUVASTATIN vs ROXADUSTAT ROSUVASTATIN vs ROXICODONE ROSUVASTATIN vs ROXITHROMYCIN

Related Pages

ROSUVASTATIN Full Profile All Incorrect dose administered Reports All Drugs Causing Incorrect dose administered ROSUVASTATIN Demographics